Kjell Heuser

Dr. Kjell Heuser

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
ABAgnes Balint Bjørke
Agnes Balint Bjørke
Cecilie Gjessing NomeCecilie Gjessing Nome
Cecilie Gjessing Nome
RFRagnhild Sørum Falk
Ragnhild Sørum Falk
LGLeif INGVALD Gjerstad
Leif INGVALD Gjerstad
ETErik Taubøll
Erik Taubøll
KHKjell Heuser
Kjell Heuser

14 January 2014 in Tidsskrift for Den norske legeforening
Verified
Journal Article
Open access
KHKjell Heuser
Kjell Heuser
KSKarolina Szokol
Karolina Szokol
ETErik Taubøll
Erik Taubøll

30 January 2023 in Tidsskrift for Den norske legeforening
Verified
Journal Article
Open access
PDF file
OHOliver Henning
Oliver Henning
KHKjell Heuser
Kjell Heuser
VLVilde Stangeby Larsen
Vilde Stangeby Larsen
EKEli Berit Kyte
Eli Berit Kyte
HKHrisimir Kostov
Hrisimir Kostov
KNKarl O. Nakken
Karl O. Nakken
30.01.2023: Klinisk oversikt - Temporallappene er de deler av hjernen som hyppigst er sete for epilepsiutvikling.

22 July 2022 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
TBToni Christoph Berger
Toni Christoph Berger
ETErik Taubøll
Erik Taubøll
KHKjell Heuser
Kjell Heuser
Pharmacological therapy of epilepsy has so far been limited to symptomatic treatment aimed at neuronal targets, with the result of an unchanged high proportion of patients lacking seizure control. The dissection of the intricate pathological mechanisms that transform normal brain matter to a focus for epileptic seizures—the process of epileptogenesis—could yield targets for novel treatment strategies preventing the development or progression of epilepsy. While many pathological features of epileptogenesis have been identified, obvious shortcomings in drug development are now believed to be based on the lack of knowledge of molecular upstream mechanisms, such as DNA methylation (DNAm), and as well as a failure to recognize glial cell involvement in epileptogenesis. This article highlights the potential role of DNAm and related gene expression (GE) as a treatment target in epileptogenesis.

13 July 2021 in Frontiers in Neurology
Verified
Journal Article
Open access
KHKjell Heuser
Kjell Heuser
MCMarco de Curtis
Marco de Curtis
CSChristian Steinhäuaer
Christian Steinhäuaer
Editorial: Glial Dysfunction in Epileptogenesis

16 July 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
LBLaura Bojarskaite
Laura Bojarskaite
DBDaniel Marelius Bjørnstad
Daniel Marelius Bjørnstad
AVAlexandra Vallet
Alexandra Vallet
KBKristin M. Gullestad Binder
Kristin M. Gullestad Binder
CCCéline Cunen
Céline Cunen
RERune Enger
Rune Enger
Perivascular spaces (PVS) are important highways for fluid and solute transport in the brain enabling efficient waste clearance during sleep. Using two-photon imaging of naturally sleeping mice we demonstrate sleep cycle-dependent PVS dynamics – slow, large-amplitude oscillations in NREM, a reduction in REM and an enlargement upon awakening at the end of a sleep cycle. By biomechanical modeling we demonstrate that these sleep cycle-dependent PVS dynamics drive fluid flow and solute transport.